ANTX Latest Press Releases

-- August 31, 2026 --

AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting Business Wire 6:00 PM

-- August 24, 2026 --

AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer Business Wire 7:00 AM

-- August 11, 2026 --

AN2 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business and Scientific Highlights Business Wire 4:00 PM

-- July 20, 2026 --

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of AN2 Therapeutics, Inc. (NASDAQ: ANTX) PRNewswire 10:30 AM

-- June 4, 2026 --

AN2 Therapeutics Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Disease Business Wire 7:00 AM

-- May 21, 2026 --

AN2 Therapeutics to Present at 2026 Jefferies Global Healthcare Conference Business Wire 7:00 AM

-- May 11, 2026 --

AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights Business Wire 4:01 PM

-- May 7, 2026 --

AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum Business Wire 4:01 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software